Therapy Areas: Inflammatory Diseases
15 January 2019 - - US-based business intelligence and market research company Spherix Global Insights has published the third annual edition of RealWorld Dynamix: Biologic/JAK Switching in IBD, ...
15 January 2019 - iReceptor Plus stated on Tuesday that European Union (EU) and the Canadian government have awarded EUR8.4m under its international consortium project to promote human immunological d...
14 January 2019 - Ocular Therapeutix, a company engaged in the formulation, development, and commercialisation of advanced therapies for diseases and conditions of the eye through using its bioresorba...
11 January 2019 - - US-based biopharmaceutical company Ocular Therapeutix, Inc. (NASDAQ: OCUL) has submitted a supplemental New Drug Application to the US Food and Drug Administration for Dextenza (de...
11 January 2019 - - Israeli biopharmaceutical company ChemomAb has dosed the first patient in a Phase 1b repeated dose clinical trial with CM-101 in non-alcoholic fatty liver disease (NAFLD) patients,...
11 January 2019 - - US-based Quanterix Corp. (NASDAQ: QTRX), a company digitizing biomarker analysis with the goal of advancing the science of precision health, has launched of its Simoa SP-X Imaging ...
Related Headlines